Summer Meeting 2016

Event Details

Summer Meeting June 14th, 2016

Program moderated by Ketil Widerberg, General Manager Oslo Cancer Cluster

Update and outlook Oslo Cancer Cluster

Ketil Widerberg, General Manager

Keynote: Commercializing cell therapy –what is Thermo Fisher’s role?

Øystein Aamellem, Leader Cell Therapy, Thermo Fisher Scientific

Keynote: Novo Seeds: You plant the innovation seed. We help it grow!

Christina Trojel-Hansen, PhD; Investment Associate Novo Seeds

Diana Muftic, PhD; Investment Associate Novo Seeds

Coffee and Networking Break with light refreshments
New Kids on the Block: Presentation of new Oslo Cancer Cluster members
DNB International Healthcare – our international operations and our focus on building the Norwegian healthcare industry

Benedicte Bakke; Senior Advisor, International Healthcare, International Corporate Division – ‎DNB


Celgene – 10 years in Europe and the way forward

Odd-Jan Gjeruldsen; Area Manager Norway


Why HealthCap has joined Oslo Cancer Cluster and what we can offer

Ludvik Sandnes; Special Advisor HealthCap


Curida – Turning Innovation into Industry

Per S. Thoresen; Chairman of the Board, Curida


Crown Bioscience: Connecting Science to Patients – Immuno-Oncology and Translational Oncology Platforms

Dr. Eric Murphy; Global Scientific Director Translational Oncology, Crown Bioscience


Questback – Capturing Wisdom

Odd Inge Hellesylt; Healthcare Lead Questback


Larix – points to consider in selecting a clinical CRO

Ole Wiborg; Chief Business Officer Larix
Radiopharmacy at IFE – history and future prospects

Bente Tange Harbø; Sektordirektør IFE


Only Oncology: Communication Planning and Company Introduction

Ian Triggs; CEO ONLY Oncology at Prime Medica




Print This Post